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Abstract
Survival data analysis becomes complex when the proportional hazards assumption is violated at pop-
ulation level, or when crude hazard rates are no longer estimators of marginal ones. We develop a Bayesian
survival analysis method to deal with these situations, based on assuming that the complexities are induced
by latent cohort or disease heterogeneity that is not captured by covariates, and that proportional hazards
hold at the level of individuals. This leads to a description from which risk-specific marginal hazard rates
and survival functions are fully accessible, ‘decontaminated’ of the effects of informative censoring, and
which includes Cox, random effects and latent class models as special cases. Simulated data confirm that
our approach can map a cohort’s substructure, and remove heterogeneity-induced informative censoring
effects. Application to data from the ULSAM cohort leads to plausible alternative explanations for previous
counter-intuitive inferences on prostate cancer. The importance of managing cardiovascular disease as a
comorbidity in women diagnosed with breast cancer is suggested on application to data from the AMORIS
study.
Keywords: survival analysis; heterogeneity; informative censoring; competing risks
1 Introduction
The analysis of survival data is often complicated by latent cohort or disease heterogeneity and informative
censoring arising from competing risks. In its simplest form, such heterogeneity could reflect unobserved
covariates, but a cohort could also exhibit variations in risk associations or in the temporal features of base
hazard rates. Association heterogeneity tends to cause a proportional hazards assumption to be violated
at cohort level. Moreover, if latent heterogeneity affects several risks in a correlated manner, it may cause
informative censoring. A cohort is subject to informative censoring if the event times of the primary and
non-primary (competing) risks are statistically dependent. Unfortunately, one cannot infer the presence or
absence of event-time correlations from survival data alone [1, 2]. Unaccounted for risk correlations can lead
to incorrect inferences or interpretations [3, 4, 5, 6, 7], and the importance of having reliable epidemiological
tools for isolating effects from interrelated comorbid diseases is increasingly recognised [8]. In discussing
informative censoring in survival data, we shall refer to the crude cause-specific hazard rates and survival
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Figure 1: Effects and signatures of heterogeneity and informative censoring: Panel (a) illustrates the danger
of misinterpreting Kaplan-Meier (KM) estimators in the presence of competing risks. The KM-curves for the
lower and upper quartiles (LQ and UQ) of a covariate associated with the primary risk are presented for two
simulated cohorts, sharing identical primary risk characteristics. In the first cohort (solid lines) no informative
censoring is present. The second cohort (dashed lines) is subjected to a competing risk whose event times
correlate with those of the primary risk. In the absence of informative censoring, the LQ versus UQ KM-
curves are similar. In the presence of informative censoring, the LQ and UQ KM curves suggest completely
different primary risk survivals. Characteristics for these cohorts are based on those of Cohort B, described
in Section 3, where risk r = 2 simulates the competing risk. The crossing log-log survival curves in panel (b)
indicate a violation of the proportional hazards assumption in the different smoking strata in the ULSAM
cohort [35, 36]. The non-proportional hazards for prostate cancer (r =PC) smoking status in combination
with stratum dependent competing risks, is suggestive of heterogeneity; the KM-estimates indicate that the
survival of smokers is greater than that of ex- and non-smokers (an alternative view is suggested from our
analysis; see Section 4).
functions, in which the influence of competing risks is present, and their marginal counterparts, which have
been decontaminated of the effects of competing risks. Inference from survival data of the marginal risk
characteristics, which describe the hypothetical situation where all non-primary risks were disabled, requires
that the competing risk problem is addressed [9].
Conventional survival analysis tools, such as Kaplan-Meier estimators [10] and Cox regression [11], cannot
distinguish between different mechanisms of informative censoring. True protectivity and aetiology effects
describe direct associations of covariates with the primary risk that would have persisted even in the absence
of competing risks, whereas false protectivity and aetiology effects would have disappeared. The interpretation
of Kaplan-Meier curves or cause-specific hazard ratios in Cox regression can therefore be dangerous when there
are many censoring events. This is demonstrated in Figure 1(a), which shows that, due to informative censoring
by a competing risk, the covariate-conditioned estimators for the primary risk differ significantly between two
simulated heterogeneous cohorts, even if these cohorts have identical primary risk characteristics. In both
cohorts, the relevant covariate was associated with increased hazard against the primary risk for one half
of the cohort, and with reduced hazard for the other half; informative censoring was simulated in one cohort
through the introduction of a competing risk, with the covariate being associated with increased hazard against
the competing risk for those cohort members for which the covariate was associated with increased hazard
against the primary risk. However, Kaplan-Meier estimators can offer clues as to the presence of heterogeneity
and informative censoring in a cohort. Inspecting covariate-stratified risk-specific Kaplan-Meier estimators
can confirm violation of the proportional hazards assumption, as is evident for the cohort in Figure 1(b).
Many approaches have been used to model residual cohort heterogeneity, usually building on Cox-type
cause-specific hazard rates, such as random effects models e.g. [12, 4, 13, 14, 15, 16, 17, 18, 19, 20, 21] and
latent class models e.g. [22, 23, 24, 25, 26]. However, most random effects models quantify only the hazard
rate of the primary risk. They can capture some consequences of cohort heterogeneity, but without also
modelling non-primary risks it is impossible to deal with the competing risk problem. Another attempt to
address competing risks is made in [27] where the authors parametrise the covariate-conditioned cumulative
incidence function, an estimator of the cause-specific cumulative probability. The approach is conceptually
similar to that of [11]; both model the primary risk profile in the presence of all competing risks. Cumulative
incidence functions appear more intuitive than hazard rates as they estimate the cause-specific cumulative
event probability, irrespective of the presence of correlated event times. However, expressing the likelihood
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function counterpart of the cumulative incidence function is more cumbersome than expressing it for the hazard
rates in [11]. While [27] thus quantifies cause-specific cumulative probabilities, the competing risk problem
is still not addressed. Further developments involve e.g. alternative parametrisations [28, 29], application to
the cumulative incidence of non-primary risks [30], and the inclusion of frailty factors [31]. Other authors
have focused on identifying which mathematical constraints need to be imposed on multi-risk survival analysis
models in order to circumvent the identifiability problem of [1], and infer the joint event-time distribution
unambiguously from survival data e.g. [32, 33, 34].
Informative censoring can either appear at cohort-level as a consequence of residual (disease- or patient-)
heterogeneity not captured by the recorded covariates, or the different risks are dependent already at the
level of individual patients. We refer to the former as heterogeneity-induced informative censoring, and to
the latter as individual-level risk dependence; one cannot distinguish between these on the basis of survival
data alone. In this paper, we assume informative censoring to be of the heterogeneity-induced type; this is
an unverifiable assumption. However, it is much weaker than assuming risk independence, and still found to
impose sufficient constraints to enable us to derive exact formulae for cause-specific marginal hazard rates and
survival functions. In this paper, we develop a generic model, that builds upon the random effects and latent
class approaches, from which relative frailties, covariate associations, and base hazard rates for each latent
class and for all risks can be estimated. Our choice of simultaneously modelling all risks exploits the cohort
information more fully than traditional analyses focused only on the primary risk, and our analysis employs
Bayesian model selection for optimal cohort substructure and parameter estimation.
In Section 2 we first classify the distinct levels of ‘risk complexity’ from the competing risk perspective in
a cohort, and define the concept of heterogeneity-induced informative censoring, before presenting the math-
ematical development behind our latent class approach to survival analysis. In Section 3 the effectiveness of
our analysis to characterise heterogeneous cohorts is demonstrated, via application to simulated survival data.
The results obtained are compared with those obtained from Kaplan-Meier estimators and Cox regression.
In Sections 4 and 5 we apply our method to real prostate and breast cancer survival data from the ULSAM
longitudinal cohort [35, 36] and the AMORIS cohort [37, 38], respectively. The application to the ULSAM data
leads to appealing and transparent new explanations for previously counter-intuitive inferences. Age-related
survival differences between women diagnosed with breast cancer were found on application to data from the
AMORIS cohort. In Section 6 we summarise our findings.
2 Heterogeneity-induced informative censoring
Understanding the relationships between heterogeneity-induced informative censoring, appearing at the cohort
level, and risk dependence at individual level, is critical to any analysis that seeks to address the issue of residual
cohort heterogeneity. This is formalised in Section 2.1. In Section 2.2 we discuss the extent to which different
risk (in)dependence assumptions limit survival analysis. Our present approach assumes that risk event-time
correlations are caused by residual cohort heterogeneity. While this assumption is weaker than assuming risk
independence, it still leads to intuitive and transparent parametrisations of hazard rates, and allows us to
overcome informative censoring and make quantities decontaminated of its effects accessible. Formulae for
marginal cause-specific survival functions and hazard rates are derived in Section 2.3. In Section 2.4 the
we outline our latent class approach to modelling heterogeneous cohorts (with further details and identities
given in Appendix A). Details of our Bayesian approach for optimal cohort parameter estimation are given in
Section 2.5, and in Section 2.6 the various outputs of our analysis and their benefits are discussed.
2.1 Connection between cohort-level and individual-level descriptions
The standard mathematical relations of multi-risk survival analysis can be derived directly from the underlying
joint event-time distributions. Below, we formalise the relationships between the cohort as a whole and its
individual members for a number of quantities of interest; the index i is used to denote quantities specific to
individual i, with no such index being present for cohort-level quantities. We imagine a cohort of N individuals,
who are each subject to R true risks, labelled by r = 1 . . . R, and an end-of-trial censoring event denoted by
r = 0. In the interest of readability, products and summations which run over the true risks and the end-of-
trial risk shall be written as
∏
r and
∑
r respectively, such that r = 0, . . . , R; should a particular risk r
′ be
excluded then the product shall be written as
∏
r 6=r′ . Summations over the cohort run over all individuals,
and shall be written as
∑
i, where i = 1, . . . , N .
The function p(t0, . . . , tR) shall be used to describe, for the cohort as a whole, the (unknown) probability
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density of the joint event times (t0, . . . , tR), where tr ≥ 0 is the time at which risk r triggers an event. The
personalised event-time distribution of any individual i in this cohort is denoted by pi(t0, . . . , tR). The cohort-
level risk event-time density is, by definition, a direct average of the personalised risk event-time densities, such
that p(t0, . . . , tR) = N
−1
∑
i pi(t0, . . . , tR). The covariate-conditioned cohort-level risk event-time distribution
describes the risk event-time statistics of the sub-cohort of those individuals satisfying zi = z, and is the
average of their personalised event-time distributions, such that p(t0, . . . , tR|z) = n−1z
∑
i, zi=z
pi(t0, . . . , tR),
where nz =
∑
i, zi=z
1.
The crude cause-specific hazard rates follow from the joint event-time distribution. At cohort level, the
covariate-conditioned cause-specific hazard rates are given by,
hr(t|z) = 1
S(t|z)
∫ ∞
0
. . .
∫ ∞
0
dt0 . . .dtR p(t0, . . . , tR|z)δ(t− tr)
∏
r′ 6=r
θ(tr′ − t), (1)
where S(t|z) represents the covariate-conditioned survival function, the delta-distribution δ(x) is defined by
the identity
∫∞
−∞dx δ(x)f(x) = f(0), and the step function is defined as θ(x > 0) = 1 and θ(x < 0) = 0. The
cohort-level covariate-conditioned survival function, S(t|z), is given by,
S(t|z) = e−
∑
r′
∫
t
0
ds hr′ (s|z). (2)
The covariate-conditioned joint risk event-time probability density, p(t, r|z), is given by,
p(t, r|z) = hr(t|z)e−
∑
r′
∫
t
0
ds hr′(s|z). (3)
Analogous relations define the cause-specific hazard rate hir(t), the survival function Si(t), and the joint risk
event-time probability density pi(t, r), for each individual i. These relations are of identical form to those
above, though individual-level quantities replace cohort-level quantities and explicit covariate-conditioning is
unnecessary.
The relationship between quantities at cohort-level and at individual-level is simple for those which depend
linearly on the event-time distribution. For instance, the cohort-level survival function is the average of the
individual survival functions, S(t|z) = n−1
z
∑
i, zi=z
Si(t), and the cohort-level risk event-time probability
density is given by p(t, r|z) = n−1
z
∑
i, zi=z
pi(t, r), with nz =
∑
i, zi=z
1. In contrast, cohort-level expressions
for quantities that depend on the risk event-time distribution in a more complicated way, such as crude
cause-specific hazard rates, are not direct averages over their individual-level counterparts. The cohort-level
cause-specific hazard rates, for instance, are (Appendix A.1),
hr(t|z) =
∑
i,zi=z
hir(t)e
−
∑
r′
∫
t
0
ds hi
r′
(s)
∑
i,zi=z
e
−
∑
r′
∫
t
0
ds hi
r′
(s)
. (4)
The cause-specific cumulative incidence function, Fr(t) =
∫ t
0
dt′ S(t′)hr(t
′), describes the probability that
event r has been observed at any time prior to time t. Although Fr(t) refers to risk r specifically, it can be
heavily influenced by other risks. Without additional assumptions, it is not possible to distinguish between the
cumulative incidence being small because event r is intrinsically unlikely, or because it tends to be preceded
by other (competing) events r′ 6= r.
2.2 Risk complexity in heterogeneous cohorts
In this section, we explore the consequences of risk event-time correlations and cohort-level heterogeneity.
Cohorts are generally expected and allowed to be heterogeneous in terms of covariates. Here we refer to
heterogeneity in terms of the relationship between covariates and risks. A homogeneous cohort is one in which
the relationship between an individual’s covariates and their risk is uniform throughout the cohort. Here the
personalised event-time distribution pi(t0, . . . , tR) can depend on i only through an individual’s covariates zi;
there can be no informative censoring, and the crude and marginal cause-specific hazard rates and survival
functions are fully identical. In heterogeneous cohorts, in contrast, the individuals have further relevant
features which are not captured by the available covariates. Now a gradual ‘filtering’ will be observed: high-risk
individuals will drop out early, causing time dependencies at cohort-level that have no counterpart at individual
level. In such cohorts, it is quite possible to have uncorrelated individual-level risks, pi(t0, . . . , tR) =
∏
r pi(tr),
but to have correlated covariate-conditioned cohort-level risks, p(t0, . . . , tR|z) 6=
∏
r p(tr|z).
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Table 1: Risk complexity to capture cohort heterogeneity, risk event-time correlations, and competing risks
Risk complexity Individual Cohort
I
Homogenous cohort
No competing risks at individual level
No competing risks at cohort level
pi(t0, . . . , tR) =
∏
r p(tr|zi) p(t0, . . . , tR|z) =
∏
r p(tr|z)
II
Heterogeneous cohort
No competing risks at individual level
No competing risks at cohort level
pi(t0, . . . , tR) =
∏
r pi(tr) p(t0, . . . , tR|z) =
∏
r p(tr|z)
III
Heterogeneity-induced competing risks
No competing risks at individual level
Cohort level competing risks
pi(t0, . . . , tR) =
∏
r pi(tr) p(t0, . . . , tR|z) 6=
∏
r p(tr|z)
IV
Heterogeneous cohort
Individual level competing risks
Cohort level competing risks
pi(t0, . . . , tR) 6=
∏
r pi(tr) p(t0, . . . , tR|z) 6=
∏
r p(tr|z)
Risk event-time correlations in a cohort can be generated at different levels. This leads to natural hierarchy
of cohorts in terms of risk complexity, as summarised in Table 1, with implications for the applicability or
interpretation of survival analysis methods. Assuming statistically independent risk event-times at cohort-level
is a commonly adopted, and practical, approach in studies where the interpretation of cause-specific hazards
extracted from Cox regression is desirable e.g. when aiming to design clinical interventions from knowledge
of the effects of modifiable covariates on a particular disease. This assumption is valid only in cohorts with
risk complexity levels I and II. At level II there is still no competing risk problem, but heterogeneity may
demand parametrisations of crude cohort-level primary hazard rates that are more complex than those of the
Cox model. This is the rationale behind random effects models, and behind the latent class models of [24].
However, most of these approaches still only model the primary risk, and therefore cannot handle cohorts
beyond level II.
In this paper we focus on developing survival analysis tools to investigate cohorts with risk complexity level
III. The event-times of all risks are assumed to be statistically independent for each individual, but residual
heterogeneity leads to risk correlations at cohort-level. Here, the correlations between cohort-level event-times
have their origin strictly in correlations between disease susceptibilities and covariate associations of individuals.
For example, someone with a high hazard rate for event A may also be likely to have a high hazard rate for
event B, for reasons not explained by their covariates. At this level of risk complexity, heterogeneity-induced
competing risks phenomena will be observed, as the risk correlations cause informative censoring. Cohorts of
risk complexity level IV are the most complex, with the event-times of different risks being correlated at both
individual and cohort level. Modelling tools for such cohorts are not explored in this paper.
2.3 Separating direct from indirect associations and quantifying informative cen-
soring
The assumption of heterogeneity-induced competing risks allows us to investigate analytically the effects of
informative censoring. With this assumption, the risk event-time marginal distributions are accessible, and it
therefore becomes possible to develop expressions for the marginal cause-specific hazard rates and survival func-
tions, in addition to their crude counterparts. The cause-specific event-time probability at the individual-level,
given the assumption of risk independence, is given by pi(tr) = h
i
r(t)e
−
∫
t
0
ds hir(s). The cohort-level covariate-
conditioned risk event-time marginals are therefore given by p(tr|z) =
∑
i,zi=z
hir(t)e
−
∫
t
0
ds hir(s)/
∑
i,zi=z
1,
and can be used to develop expressions for the marginal survival functions and hazard rates1.
Given the assumption of heterogeneity-induced competing risks, the crude cause-specific hazard rates
hr(t|z) and their marginal counterparts h˜r(t|z) are given by
hr(t|z) =
∑
i,zi=z
hir(t)e
−
∑
r′
∫
t
0
ds hi
r′
(s)
∑
i,zi=z
e
−
∑
r′
∫
t
0
ds hi
r′
(s)
, h˜r(t|z) =
∑
i,zi=z
hir(t)e
−
∫
t
0
ds hir(s)
∑
i,zi=z
e
−
∫
t
0
ds hir(s)
. (5)
1The marginal survival functions and hazard rates follow from S˜r(t|z) =
∫
∞
t
dtr p(tr |z) and h˜r(t|z) = −
d
dt
log S˜r(t|z).
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Table 2: Personalised cause-specific hazard rates, for each of the R active risks, to capture latent cohort
heterogeneity
M = 1
Heterogeneous frailties
Homogeneous associations
Homogeneous base hazard rates
hir(t) = λr(t)e
βℓ0r +
∑
µ
βµr z
µ
i
M = 2
Heterogeneous frailties
Heterogeneous associations
Homogeneous base hazard rates
hir(t) = λr(t)e
βℓ0r +
∑
µ
βℓµr z
µ
i
M = 3
Heterogeneous frailties
Heterogeneous associations
Heterogeneous base hazard rates
hir(t) = λ
ℓ
r(t)e
βℓ0r +
∑
µ
βℓµr z
µ
i
The crude and marginal cause-specific hazard rates will generally have different values. In the marginal cause-
specific hazard rate, h˜r(t|z), the probability that individual i survives until time t is given by exp[−
∫ t
0
ds hir(s)].
The probability of survival until time t for individual i in the crude cause-specific hazard rate, hr(t|z), in
contrast, depends on all risks. The crude cause-specific survival function Sr(t|z), and its marginal counterpart
S˜r(t|z), are given by
Sr(t|z) = e−
∫
t
0
ds hr(s|z), S˜r(t|z) =
∑
i,zi=z
e
−
∫
t
0
ds hir(s)∑
i,zi=z
1
. (6)
The marginal cause-specific survival function, S˜r(t|z), depends only on the risk r, whereas its crude counterpart
depends on all risks through the crude hazard rate hr(t|z). We conclude that the assumption that competing
risks, if present, are induced by residual cohort or disease heterogeneity, leads to relatively simple explicit
formulae for the marginal cause-specific quantities of interest. It remains to identify the minimal level of
description required for evaluating these formulae, and to determine how the required information can be
estimated from survival data.
2.4 Modelling the heterogeneous cohort
In this section we develop our latent class framework. We assume a heterogeneous cohort to be comprised of
L initially unknown sub-cohorts, or latent classes, labelled by ℓ = 1, . . . , L. Each class obeys the proportional
hazards assumption, but the cohort collectively need not. Each individual from the cohort is assumed to
belong to exactly one latent class. The relative influence of each class depends on the fraction of individuals
belonging to that class. At the heart of our model are the personalised cause-specific hazard rates, hir(t),
being of the Cox form and obeying the assumption of proportional hazards. These personalised hazard rates
shall depend on cause-specific and possibly class-specific frailty, association, and base hazard rate parameters.
Inevitably, modelling all risks and their correlations leads to models with more parameters than those which
model only the primary risk. To avoid overfitting, three variants of the personalised cause-specific hazard rates
are introduced, with differing degrees of heterogeneity and complexity, as summarised in Table 2.
The frailty parameters βℓ0r capture effects that cannot be attributed to the included covariates, within class
ℓ for risk r. The association parameters βℓµr quantify how strongly each of the µ = 1, . . . , P covariates influence
the personalised hazard rate for risk r and class ℓ. The functions λℓr(t) describe the cause-specific personalised
base hazard rates, for risk r, for each individual in class ℓ. They are parametrized through a spline construction
(Appendix A.6); the number K of spline time points required increases with the irregularity of the base hazard
rates. Upon representing the set of those individuals belonging to class ℓ by Iℓ, all quantities of the form∑
i,zi=z
f(hir(t))/
∑
i,zi=z
1, i.e. all covariate-conditioned averages over expressions involving the personalised
cause-specific hazard rates, can then be written as
∑
ℓ wℓ(z)f(h
ℓ
r(t|z)), where the class membership fractions,
wℓ(z), give the probability that a randomly drawn individual with covariates z will belong to class ℓ. In this
paper, these fractions are chosen to be independent of the covariates; this amounts to assuming that all classes
have identically distributed covariates. It is, in principle, easy to extend our model to incorporate covariate-
conditioned class weightings, as in e.g. [24], though this would introduce additional model parameters.
The various crude and marginal quantities which describe a cohort are given below in terms of our latent
class parametrisation for the fully heterogeneous variant of the personalised cause-specific hazard rate (M = 3);
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corresponding expressions are easily obtained for the simpler hazard rate variants on substitution of class-
independent association(s) (M = 1) and class-independent base hazard rate(s) (M = 2), as appropriate. We
adopt the following compact notation. The effect of the frailty and associations, for each true risk r and
class ℓ, are summarised by the product βℓr · z = βℓ0r +
∑
µ β
ℓµ
r z
µ. The end-of-trial risk (r = 0) is assumed
to be independent of the covariates, and accordingly the class-independent associations for the censoring risk
are defined to be zero, β0 = 0. The integrated base hazard rates are denoted by Λ
ℓ
r(t) =
∫ t
0
ds λℓr(s). The
parametrised crude and marginal hazard rates, for risks r = 1, . . . , R, are now given by,
hr(t|z) =
∑
ℓ wℓ λ
ℓ
r(t)e
βℓ
r
·z−
∑
R
r′=1
exp(βℓ
r′
·z)Λℓ
r′
(t)
∑
ℓwℓ e
−
∑
R
r′=1
exp(βℓ
r′
·z)Λℓ
r′
(t)
, h˜r(t|z) =
∑
ℓ wℓ λ
ℓ
r(t)e
βℓ
r
·z−exp(
ˆβ
ℓ
r
·z)Λℓr(t)∑
ℓ wℓ e
− exp(βℓ
r
·z)Λℓr(t)
. (7)
The corresponding crude and marginal cause-specific survival functions are given by,
Sr(t|z) = exp
(
−
∫ t
0
ds hr(s|z)
)
, S˜r(t|z) =
∑
ℓ
wℓ e
− exp(β
ℓ
r
·z)Λℓr(t). (8)
The crude cause-specific hazard rate is influenced by all risks, hence the same is true for the crude cause-
specific survival function. In Appendix A.2 the crude and marginal survival are shown to be identical in
the case where there is one risk only, i.e. in the absence of any potential informative censoring. Our latent
class model leads in the same manner to an intuitive and easily interpreted formulation of the cause-specific
cumulative incidence function, in which the role of all model parameters is completely transparent:
Fr(t|z) =
∫ t
0
dt′ e−Λ0(t
′)
∑
ℓ
wℓ λ
ℓ
r(t
′)eβ
ℓ
r
·z−
∑
R
r′=1
exp(βℓ
r′
·z)Λℓ
r′
(t′). (9)
Finally, our approach also offers retrospective determination of an individual’s class membership probability,
given their covariates z and their survival information (t, r). Following Bayesian arguments (as detailed in
Appendix A.3), the probability that an individual belongs to class ℓ, given their covariates and survival
information, is found to be
p(ℓ|t, r, z) = wℓ λ
ℓ
r(t)e
β
ℓ
r
·z−
∑
R
r′=1
exp
(
β
ℓ
r′
·z
)
Λℓ
r′
(t)
∑L
ℓ′=1 wℓ′ λ
ℓ′
r (t)e
βℓ
′
r
·z−
∑
R
r′=1
exp
(
βℓ
′
r′
·z
)
Λℓ
′
r′
(t)
. (10)
We define the retrospective class weight fℓ of a class as the fraction of the cohort for which, according to (10),
ℓ is the most probable class, i.e. the fraction of individuals i for which argmaxℓ′=1...L p(ℓ
′|ti, ri, zi) = ℓ. Note
that one will generally find that (f1, . . . fL) 6= (w1, . . . , wL). The search for informative new covariates could
be aided by this retrospective class assignment, and thereby increase our ability to predict personalised risk in
heterogeneous cohorts. Such new covariates are expected to be features that patients who belong to the same
class, as suggested by (10), have in common.
2.5 Characterisation of cohort heterogeneity
The most appropriate choices for the personalised hazard rate model, the number of latent classes, and the
complexity of the base hazard rates are all unknown at the outset of an analysis, so their optimal values
and the corresponding optimal class weightings, frailties, associations, and base hazard rates all need to be
estimated. For this we use Bayesian inference.
The term ‘model’ shall be used to describe the combination of a particular number of latent classes, L,
a particular form of the base hazard rates having K spline time points, and a particular parametrisation of
the personalised hazard rates, M , and shall be denoted by HKLM . The parameter vector, θHKLM , denotes
the model parameters (i.e. the class weightings, the frailty, association, and base hazard rate parameters)
of model HKLM . The optimal description of a cohort, θ⋆H⋆
KLM
, is identified by finding the most probable
parameter values, θ⋆HKLM , of the most probable model, H⋆KLM . In practice, the optimal parameter values
are first determined for each model from an ensemble of candidate models before the model supported by
the greatest evidence is identified. The optimal parameter values are those which maximise the posterior
distribution, p(θHKLM |D), which gives the probability of the model parameters, θHKLM , conditioned on a
cohort’s survival data, D. The probability density, p(t, r|z), to find the earliest event occurring at time t, and
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corresponding to risk r, provides the link between our latent class model parameters and the survival data. In
terms of our latent class parametrisation, the probability density for an individual with covariate vector z to
report (t, r) is given by,
p(t, r|z) = e−Λ0(t)
∑
ℓ
wℓ λ
ℓ
r(t)e
βℓ
r
·z−
∑
R
r′=1
exp(βℓ
r′
·z)Λℓ
r′
(t). (11)
Here the parameters are those of the fully-heterogeneous personalised hazard rate (M = 3) defined in Table 2.
The data likelihood, p(D|θHKLM ) =
∏
i p(ti, ri|zi, θHKLM ), gives the joint probability of the event-time ti
and risk ri for every individual in the cohort, conditioned on their covariates, zi, and the model parameters,
θHKLM , for the model HKLM .
The posterior can be written as p(θHKLM |D) = Z−1HKLM exp(L(θHKLM , D)), where the log-likelihood is
defined as L(θHKLM , D) = log(p(D|θHKLM )p(θHKLM )), the normalisation constant is denoted by ZHKLM , and
the prior distribution over the model parameters is given by p(θHKLM ) (Appendix A.4). The contribution
to the log-likelihood from the data-likelihood, for our fully heterogeneous personalised hazard rate (M = 3)
latent class model, is given by,
log p(D|θHKLM ) = −
∑
i
Λ0(ti) +
∑
i
log
[∑
ℓ
wℓ λ
ℓ
ri(ti)e
β
ℓ
ri
·zi−
∑
R
r=1
Λℓr(ti) exp(β
ℓ
r
·zi)
]
. (12)
The optimal model, H⋆KLM is that which is supported by the greatest ‘evidence’, p(HKLM |D). In this study
all models are given identical prior probabilities, p(HKLM ). The model evidence describes the likelihood of the
model HKLM conditioned on the cohort’s survival data, D, and is proportional to the posterior normalisation
constant, ZHKLM =
∫
dθHKLM p(D|θHKLM ,HKLM )p(θHKLM |HKLM ), for that model. Here we determined the
evidence for each model from its optimal parameter values, θ⋆HKLM , through the use of Gaussian approximations
to the posteriors (Appendix A.5).
2.6 Practical tools for survival analysis
The analysis protocol described above has been implemented in our software package, ALPACA (Advanced
Latent Class Prediction And Competing Risk Analysis), using the C programming language. The frailty,
association, and base hazard rate parameters are located, for each model, by maximum a posteriori (MAP)
estimation, using a stochastic refinement of the downhill simplex method [39]. Numerical estimation of the
curvature of the posterior distribution around the location of maximum probability enables both the error
bars for the parameter estimates and the model evidence to be determined. As the search for the optimal
parameter values is achieved using a stochastic optimization algorithm, this procedure is typically performed
multiple times and the best overall estimation is selected.
A cohort’s survival data is pre-processed before application of our analysis algorithms. This involves linear
rescaling of the raw covariate values such that the transformed counterparts are described by zero average and
unit variance distributions, equivalent to the definition of Z-scores. The parameter estimates obtained using
our analysis are translated to the more familiar language of hazard ratios (HR), 95% confidence intervals (CI),
and p-values. The hazard ratio, HRℓµr , the lower and upper bounds,
−HRℓµr and
+HRℓµr respectively, of the
95% confidence interval, CIℓµr = [
−HRℓµr ,
+HRℓµr ], and the p-value associated with normalised covariate µ, can
be computed, for every event type r and each class ℓ, according to
HRℓµr = e
2βℓµr , ±HRℓµr = exp(2(β
ℓµ
r ± 1.96σℓµr )), pℓµr = 1− erf(|βℓµr |/
√
2σℓµr ). (13)
Here βℓµr and σ
ℓµ
r are the estimated association parameter and its uncertainty for covariate µ, |βℓµr | denotes
the magnitude of the estimated association, and the error integral is given by erf(t) = (2/
√
π)
∫ t
0 dx e
−x2 .
As a consequence of our data pre-processing, the magnitudes of the effects for different associations can be
directly compared.
Crude and marginal survival curves, cumulative incidence curves, and retrospective class allocations are
known once the model parameters have been estimated. Any differences between crude and marginal (covariate-
conditioned) survival curves are indicative of the extent to which competing risks are present in a cohort
subject to heterogeneity-induced informative censoring. False protectivity effects should be suspected if the
crude survival function exceeds the marginal survival function; the opposite would suggest the influence of
false exposure. Class-specific marginal survival may offer valuable insight into the expected progression of
8
individuals belonging to different latent classes. Expressing the marginal cause-specific survival (8), S˜r(t|z),
as the weighted sum of cause- and class-specific survival, S˜ℓr(t|z), as given by,
S˜ℓr(t|z) = e− exp(β
ℓ
r
·z)Λℓr(t), (14)
allows the class-specific marginal survival for each of the latent classes to be compared. Similarly, the cause-
specific cumulative incidence function (9) can be expressed as a weighted sum of its class-specific components,
F ℓr (t|z), given by,
F ℓr (t|z) =
∫ t
0
dt′ e−Λˆ0(t
′) λˆℓr(t
′)e
ˆβ
ℓ
r
·z−
∑
R
r′=1
exp(
ˆβ
ℓ
r′
·z)Λˆℓ
r′
(t′), (15)
such that Fr(t|z) =
∑
ℓ wℓF
ℓ
r (t|z). The class- and cause-specific cumulative incidence provides information
about the relative occurrence of events for each latent class and each cause at any time.
Retrospective class assignment, by identification of the most probable latent class to which an individual
belongs using (10), can offer additional insight into differences between latent classes. Retrospectively allocated
class-conditioned time-to-event distributions may offer clues as to the expected survival time for members
of the different classes. The detection of differences between covariate distributions for those individuals
retrospectively assigned to different latent classes offers a potentially powerful means of identifying novel
informative covariates.
3 Application to simulated survival data
In this section we present the results of applying our algorithms to simulated data (see Appendix B), modelling
a variety of conditions. The effectiveness of our algorithm to characterise a heterogeneous cohort with three
latent classes, two of which differ only in their base hazard rates, is demonstrated in Section 3.1. In Section 3.2
we test the ability of our method to accurately characterise a cohort in the presence of heterogeneity-induced
informative censoring. The model space searched for the analysis of each simulated cohort covered all combi-
nations of latent classes between one and four (i.e. L = 1− 4), base hazard rate complexities between one and
eight (i.e. K = 1− 8), and all variants of the personalised hazard rate (i.e. M = 1, 2, 3). Parameter estimates
were obtained for each model at least five times; the model with the greatest overall evidence was selected for
cohort estimation.
Since the class membership of every individual is known when using simulated data, the accuracy of the
retrospective class allocation algorithm (10) can be measured as the fraction of correctly assigned individuals.
The performance of (10) will, of course, depend on the quantitative features of a cohort; it is reasonable to
expect that retrospective class assignment should perform most effectively when the differences between latent
classes are pronounced, and that the algorithm may struggle when the latent classes do not differ significantly.
It is important to note that, even if all parameters were known exactly, due to the stochasticity of event times,
class allocation will never be perfectly accurate2.
3.1 Revealing heterogeneity and cohort sub-structure
Our analysis is first applied to simulated data, modelling a heterogeneous cohort having three latent classes
(L = 3), but free of informative censoring. The characteristics of Cohort A are given in Table 3; the three
latent classes are of equal size, each individual i has three covariates (z1i , z
2
i , z
3
i ) and is subject to either one
real risk or end-of-trial censoring at time t = 20. The personalised cause-specific hazard rates of individuals in
Cohort A have class-dependent associations and base hazard rates (i.e. M = 3). The associations of individuals
belonging to classes ℓ = 1 and ℓ = 2 are identical; these classes differ only in that the base hazard rate of class
ℓ = 1 is time-independent whereas that of class ℓ = 2 increases exponentially with time. The base hazard rate
of class ℓ = 3 is time-independent, though it differs from that of class ℓ = 1.
The estimation of such a cohort is challenging even in the absence of informative censoring; to successfully
characterise Cohort A, any method must be able to identify the three latent classes, distinguishing between
two classes which differ only in their base hazard rates. The effectiveness of our analysis to characterise Cohort
2A fundamental limit on the accuracy of retrospective allocation can be determined using the retrospective allocation and
event time probability relations under the assumption of an infinitely large cohort from which the parameters have been extracted
perfectly. For a cohort subject to one risk, having two latent classes of equal size, a class-independent constant base hazard rate
and only one covariate, the best possible allocation quality in the case where β11
1
= −β21
1
= 2 is about 83%.
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Table 3: Modelling a heterogeneous cohort: The parameters used to generate simulated data modelling a
cohort having three latent classes, one real risk, and with end-of-trial censoring at time t = 20.
Cohort A: (L = 3,M = 3)
Heterogeneity and class-dependent base hazard rates
Class, ℓ = 1 Class, ℓ = 2 Class, ℓ = 3
wℓ 1/3 1/3 1/3
λℓ1(t)e
βℓ0
1 3/10 et/4/100 1/10
βℓ11 2 2 -2
βℓ21 0 0 0
βℓ31 0 0 0
A is summarised in Figure 2, which shows the estimated associations and base hazard rates for cohort sizes
of N = 20000, N = 2000, and N = 200. The association parameters were accurately estimated for cohort
sizes of N = 2000 and N = 20000, and the estimated and true base hazard rates are sufficiently close, for
each of the classes, for the model supported by the greatest evidence to be considered a good estimation of
the true cohort structure. Although it is clear that a sample size of N = 200 is insufficient for Cohort A
to be accurately estimated, it is noteworthy that, despite such a meagre sample size, our analysis correctly
reports the cohort to be comprised of three latent classes, and the estimated associations are accurate (within
the estimated uncertainty) for covariates 2 and 3 for all three classes, and are accurate for classes 1 and 3 for
covariate 1.
The optimal models reported for data set sizes N = 20000 and N = 2000 were H⋆KLM = (K=4, L=3,M=
3) and H⋆KLM = (K = 3, L= 3,M = 3), respectively. In total, 23 parameters (two weights, and for each of
the three latent classes one frailty, three associations, and three modifiable spline points for the parametrised
base hazard rate approximation) were estimated for the optimal model for the N = 20000 data set. As the
Bayesian model selection stage of our analysis balances complexity of a particular model against the evidence
for it in the survival data, it is unsurprising that models containing fewer parameters were found to be optimal
for the N = 2000 and N = 200 data sets, having 20 and 16 parameters respectively. Ultimately, there is not
enough information available in the N = 200 data set to justify the selection of a model having the required
complexity to accurately describe Cohort A and here the optimal model H⋆KLM = (K = 3, L= 3,M = 2) is
reported, which has class-independent base hazard rates.
Our analysis correctly indicates that in Cohort A only covariate 1 has a statistically significant association
with hazard for the primary risk. The estimates for each of the three classes for the N = 2000 data set are
(within the estimated uncertainty) in agreement with the true values (ℓ = 1: β111 = 1.90± 0.12, HR=46, 95%
CI=[29,72], p<10−7; ℓ = 2: β211 = 1.91± 0.11, HR=45, 95% CI=[28,70], p<10−7; ℓ = 3: β311 = −2.16± 0.14,
HR=0.013, 95% CI=[0.008,0.023], p<10−7). The associations for covariates 2 and 3 were correctly estimated
for all three data sets, and found to be statistically insignificant (according to p-value) in all three latent
classes, and the 95% CI included the true HR of unity in all cases. As heterogeneity is not accounted for in a
standard Cox regression, it should be expected that the application of such an analysis to Cohort A would be
likely to yield incorrect estimates. Indeed, Cox regression produces an erroneous interpretation of the Cohort
A data with N = 2000, indicating that covariates 1 and 2 are both associated with an increased hazard (cov.1:
HR=1.33, 95% CI=[1.21,1.47], p<10−7; cov. 2: HR=1.12, 95% CI=[1.01,1.23], p=0.03).
The accuracy of the estimated base hazard rates can be assessed both by visual inspection, for similarity
between the estimated and true rates (Figure 2), and numerically. The time-independent base hazard rate of
class ℓ = 3 is reliably estimated for both the N = 20000 and N = 2000 data sets. The base hazard rates of
classes ℓ = 1 and ℓ = 2 are more accurately estimated for the larger data set size; the estimated base hazard
rate of class ℓ = 1 deviates from the true rate for times greater than about t = 10 for the N =2000 analysis,
whereas deviation is not observed at times earlier than about t = 15 for the N =20000 set. The suitability
of a spline-approximation to describe the exponentially increasing base hazard rate of the class ℓ = 2 can also
be gauged by comparing the known values of the parameters, λ0 and α, obtained on fitting the generalised
form of the exponentially increasing base hazard rate, λ(t) = λ0e
αt, to the estimated base hazard rate; for the
N = 20000 data set these parameters were determined to be λ0 = 0.012 and α = 0.233 and for the N = 2000
data set they were found to be λ0 = 0.014 and α = 0.227 (the true values of these parameters are λ0 = 0.01
and α = 0.25).
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Figure 2: Bayesian estimation of a simulated heterogeneous cohort: The estimated associations and base
hazard rates for analysis of Cohort A data, as specified in Table 3, are shown along with their true values for
sample sizes N = 200, N = 2000, and N = 20000. Our method correctly identifies three latent classes, even for
the meagre sample size of N = 200. The association parameters are accurately estimated for all covariates and
all classes on analysis of Cohort A data of size N = 2000; the base hazard rates deviate only minimally from
their true value at times greater than about t = 10. The precision of the estimated associations is superior
for the data set of size N = 20000, and the estimated base hazard rates are true to their actual values even
beyond time t = 15.
Random assignment of patients to the classes of Cohort A would give an accuracy of 33%. In contrast, on
applying our class assignment algorithm to the N=20000 data set, 73% of individuals were allocated correctly;
72% and 66% of those allocated to classes ℓ = 1 and ℓ = 2 actually belonged to those classes, and 84% of those
allocated to class ℓ = 3 actually belonged to that class. Class assignment applied to the N = 2000 data set
yielded a similar accuracy for those assigned to classes ℓ = 1 and ℓ = 2, as was obtained with the N =20000
data set; 78% of those allocated to class ℓ = 3 actually belonged to that class. Despite there being insufficient
information in the N = 200 data set for the associations and base hazard rates to be accurately estimated,
overall 70% of individuals were still correctly allocated to their true class.
3.2 Effective analysis in the presence of heterogeneity-induced informative cen-
soring
Next we examine the ability of our analysis to accurately model survival in the presence of heterogeneity-
induced informative censoring. We analyse two simulated cohorts, which are identical in their primary risk
characteristics; one cohort has been modelled to simulate the effects of false protectivity whilst the other
includes the influence of false-aetiology. Cohort B and Cohort C both have two latent classes (L = 2), of equal
size, and personalised cause-specific hazard rates with class-dependent associations (i.e. of type M = 2); both
are subject to two real risks, the primary risk (r = 1) and a competing risk (r = 2), and end-of-trial censoring.
The base hazard rates are time-independent but differ between the two risks. The quantitative characteristics
of the simulated cohorts are given in Table 4.
The Bayesian-determined optimal model was found to be accurate for both cohorts on analysis of data with
N = 1500 observations; the estimated class sizes, associations, and base hazard rates were in close agreement
with their true values for both data sets (Table 4). The estimates for both Cohort B and Cohort C suggest
correctly that covariate 1 is strongly associated with an increased hazard for the primary risk in one class, and
reduced hazard in the other class. Covariates 2 and 3 were found to be statistically insignificant, according to
their respective p-values, for both classes in both cohorts. The estimates for the secondary risk, responsible
for informative censoring, are also consistent with the true values for both cohorts. Covariate 1 was found
to be associated with an increased hazard for the secondary risk in class ℓ = 1 only in Cohort B, and with a
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Table 4: Modelling heterogeneity-induced informative censoring: The estimated weights, wℓ, and association
parameters, βℓµr , for the two real risks r = 1 and r = 2, from the Bayesian-determined optimal model from
analysis of the Cohort B and Cohort C data sets with N = 1500. True parameter values are shown in brackets
to the right of the estimated values.
Cohort B (K = 1, L = 2,M = 2)
Heterogeneity-induced false protectivity
Class, ℓ = 1 Class, ℓ = 2
wℓ 0.51± 0.02 (0.5) 0.49± 0.02 (0.5)
βℓ11 1.85± 0.14 (2.0) −1.97± 0.10 (-2.0)
βℓ21 −0.05± 0.10 (0.0) −0.04± 0.07 (0.0)
βℓ31 0.15± 0.10 (0.0) 0.01± 0.09 (0.0)
βℓ12 3.17± 0.10 (3.0) −0.10± 0.07 (0.0)
βℓ22 −0.07± 0.08 (0.0) 0.03± 0.06 (0.0)
βℓ32 −0.06± 0.07 (0.0) 0.01± 0.06 (0.0)
Cohort C (K = 1, L = 2,M = 2)
Heterogeneity-induced false aetiology
Class, ℓ = 1 Class, ℓ = 2
wℓ 0.51± 0.02 (0.5) 0.49± 0.02 (0.5)
βℓ11 2.04± 0.12 (2.0) −1.94± 0.10 (-2.0)
βℓ21 −0.06± 0.07 (0.0) −0.01± 0.06 (0.0)
βℓ31 −0.02± 0.08 (0.0) 0.14± 0.06 (0.0)
βℓ12 −3.02± 0.09 (-3.0) 0.11± 0.08 (0.0)
βℓ22 −0.02± 0.06 (0.0) 0.05± 0.07 (0.0)
βℓ32 0.04± 0.07 (0.0) −0.03± 0.06 (0.0)
reduced hazard for the secondary risk for class ℓ = 1 only in Cohort C. The associations for covariates 2 and
3 were found to be statistically insignificant.
Survival estimators are shown in Figure 3 for both cohorts. False protectivity is clearly indicated in Cohort
B, as the crude survival function for the primary risk, S1, exceeds its marginal counterpart, S˜1, throughout
the trial duration. The opposite is true for Cohort C, exposing false aetiology effects (Figure 3 (a,e)). In the
presence of informative censoring, a naive interpretation of the Kaplan-Meier estimators for the primary risk,
SKM1 , conditioned on the value of covariate 1, would be highly misleading, yielding extremely poor estimates
for the lower and upper quartiles of covariate 1 due to risk correlations in the cohorts (Figure 3 (b,f)). For
example, in Cohort B the KM estimator suggests that individuals having an upper quartile value of covariate
1 are likely to have a relatively good survival against the primary risk, with about 90% surviving at the end-of-
trial time, whereas almost 50% of such individuals actually survive until this time in both cohorts; in Cohort
C the KM estimator for individuals having a lower quartile value of covariate 1 suggests no survival beyond
about half of the trial duration. It is reassuring that the marginal class-specific survival functions against the
primary risk, S˜11 and S˜
2
1 , are similar for both cohorts, given that their primary risk characteristics were indeed
identical (Figure 3 (c,g)). Our analysis correctly estimated the direct (or ‘decontaminated’) associations for
the primary risk as being identical, within the uncertainty of the parameter estimates, both in the presence of
heterogeneity-induced false protectivity and heterogeneity-induced false aetiology. The weighted class-specific
cumulative incidence are also shown (Figure 3 (d,h)).
4 Applications to prostate cancer data
Prostate cancer (PC) data are notorious for exhibiting competing risk effects [40], largely due to the fact that
the disease occurs late in life when there is an increased number of non-primary events whose incidence could
correlate with prostate cancer. Here we analyse data from the ULSAM cohort [35] and compare the outcomes
of Cox’s proportional hazards regression [11] and our present method. The ULSAM cohort has N = 2047
individuals of which 208 reported PC as the first event, as described previously [36], and we have included five
relevant covariates of the ULSAM data [35].
Smoking is suggested to have a weak protective effect against PC risk (HR=0.85, 95% CI=[0.65,1.11],
p=0.23) in the ULSAM cohort according to Cox’s proportional hazards analysis. However, as the Kaplan-
Meier estimator for PC risk stratified on smoking status (see Figure 1) does not meet the proportional hazards
assumption, any interpretations drawn from such an analysis (on the ULSAM cohort data as a whole, at least)
may be invalid. The non-proportionality of the smoking covariate-conditioned Kaplan-Meier estimator for PC
risk could be due to heterogeneity in the ULSAM cohort.
Analysis of the ULSAM cohort using our method suggests that the cohort should rather be viewed as
consisting of two distinct classes: one class (ℓ = 1) with relatively frail individuals (in terms of both primary
and secondary risk) which contains about 16% of the cohort according to retrospective class allocation, and
another class (ℓ = 2) with rather healthy individuals which contains the remainder of the cohort. The
estimated association parameters, base hazard rates, and class-specific survival functions for PC are shown in
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Figure 3: Decontaminating heterogeneity-induced false protectivity and false aetiology effects from survival
data: Survival and cumulative incidence curves from the analysis of Cohort B and Cohort C (Table 4)
simulated survival data, with N = 1500, demonstrating the effectiveness of our method to expose the influence
of heterogeneity-induced informative censoring. For Cohort B : in (a) the crude and marginal risk-specific
survival curves, Sr(t) and S˜r(t), for the primary and secondary risks; in (b) the marginal survival curves, S˜1,
and the risk-specific Kaplan-Meier estimators, SKM1 , for the lower quartile (LQ), upper quartile (UQ), and the
inter-quartile range (IQ) of covariate 1; in (c) the class- and risk-specific marginal survival curves, S˜ℓr, for the
two latent classes for both risks; in (d) the stacked weighted class-specific cumulative incidence. The same
estimators are shown for Cohort C in (e), (f), (g) and (h) respectively.
13
Figure 4: Bayesian-determined heterogeneous characterisation of the ULSAM cohort: In (a) and (b) the
associations and frailty weighted-base hazard rates for PC risk, for the two latent classes of the optimal model
H⋆KLM = (K = 3, L = 2,M = 2) obtained on analysis of the ULSAM data. The included covariates are: body
mass index (real-valued), serum Selenium level (selen, integer valued), leisure time physical activity (phys1,
discrete levels 0/1/2), work physical activity (phys2, discrete levels 0/1/2), and smoking status (smoking,
discrete levels 0/1/2). The estimated weighting of the classes for this model is w1 = 0.32±0.08, w2 = 0.68±0.08.
The retrospective weighting of the classes for this model is f1 = 0.16 (332 of 2047 patients), f2 = 0.84 (1715
of 2047 patients). In (c) the class-and risk-specific survival functions; for PC risk it is clear that the survival
of members of the frailer class (ℓ = 1) is poorer than those of the healthier class (ℓ = 2), significantly and
increasingly so for times beyond about 20 years. In (d) the class-and risk-specific survival function conditioned
on the three values of the smoking covariate (z5 = 0: non-smoker, z5 = 1: ex-smoker, z5 = 2: smoker). For
the majority of the cohort (ℓ = 2) smoking is associated with poorer survival outcomes, but for the members
of the frailer class (ℓ = 1) smokers and ex-smokers have greater survival than non-smokers.
Fig. 4 for the most probable model H⋆KLM = (K=3, L=2,M=2). The marginal survival function for PC was
found to be slightly less than the crude survival function for follow-up times exceeding about 20 years; this
is indicative of false protectivity effects for PC risk in the ULSAM cohort data. In the Bayesian-determined
two-class description of the ULSAM cohort, BMI and smoking are recognised as serious PC risk factors for
those individuals in the healthier class. In this class (ℓ = 2), smoking is associated with elevated risk of PC
(HR=4.08, 95% CI=[1.09,15.29], p=0.04), as is having a higher BMI (HR=2.77, 95% CI=[1.20,6.36], p=0.02).
Conversely, in the frailer class (ℓ = 1), smoking is associated with a decreased risk of PC (HR=0.30, 95%
CI=[0.12,0.76], p=0.01). In the frail class the regression coefficients are weaker than those of the stronger
class, and one expects the negative coefficients for e.g. BMI and smoking to reflect reverse causality: within
this group, having a higher BMI and still being able to smoke may well be an indicator of relatively good
health.
Our current explanation and interpretation of the ULSAM data is not necessarily the final one. There are
always alternative ways to do the regression. The conclusion to be drawn is that the new two-class explanation
of the ULSAM data is both probabilistically and intuitively more plausible than the one provided by the Cox
model.
5 Applications to breast cancer data
Here we summarise the results of applying our analysis to data from the Swedish Apolipoprotein Mortality
Risk Study (AMORIS), see e.g. [37, 38]. Our data set, for which competing risk analysis was presented in
[41], describes N = 1798 women from the AMORIS population, for whom baseline serum glucose, triglyceride,
and total cholesterol measurements were available within three months to three years prior to breast cancer
diagnosis. The event time is the duration between diagnosis and breast cancer death (BC), cardiovascular
disease death (CV), death from other causes, or departure from or the end of the study (censoring). Age,
fasting status, and socio-economic status data were also included as covariates.
Our analysis suggests that the cohort is best described by three latent classes, sharing the same trend of
having base hazard rates which decrease with time for BC death risk, but increase with time for CV death risk.
The largest class (ℓ = 1) contains about 66% of the cohort according to retrospective class allocation, and has
a poorer survival against BC death but a greater survival against CV death than does the second class (ℓ = 2),
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Figure 5: Bayesian-determined heterogeneous characterisation of a cohort of women from the AMORIS
population diagnosed with breast cancer: Parameter estimates for the Bayesian-determined optimal model
H⋆KLM = (K =3, L=3,M =2), obtained on analysis of data for N = 1798 women from the AMORIS pop-
ulation diagnosed with breast cancer; the estimated retrospective weighting of the classes for this model is
f1 = 0.66 (1189 of 1798 patients), f2 = 0.32 (574 of 1798 patients), f3 = 0.02 (35 of 1798 patients). In (a) and
(b) the estimated hazard associations, βℓµr , with serum glucose, triglyceride (TG), total cholesterol (TC) and
age, for BC death (r = 1) and CV death (r = 2) respectively for the dominant (ℓ = 1: red) and next largest
(ℓ = 2: green) latent classes. In (c) the frailty-weighted base hazard rates for BC and CV death (solid and
dashed lines respectively) for the two dominant latent classes; note that the base hazard rate for CV death
exceeds that for BC death for follow-up times greater than about 15 years (ℓ = 1: red, ℓ = 2: green). In (d)
the crude (solid lines) and marginal (dashed lines) cause-specific survival against BC (red lines) and CV death
(green lines); observe that the crude survival against CV death, S2, is poorer than its marginal counterpart,
S˜2.
which accounts for 32%. The smallest latent class (ℓ = 3) is almost wholly comprised of relatively younger
individuals, for whom death from other causes was reported. It is likely that the inclusion of this third class,
containing only 35 of the 1798 individuals according to retrospective class assignment, enables more effective
estimation of the other two classes, as it allows the effects of two differing groups within those reported as
having death from other causes to be distinguished. As BC and CV death shall be the focus of the remainder
of this section, parameter estimates and survival curves pertaining to the small third latent class (ℓ = 3) are
omitted. The estimated associations, base hazard rates, and marginal class-specific survival curves are shown
in Figure 5.
The largest class (ℓ = 1) has the greatest hazard for BC death, having a base hazard rate which exceeds
that of the second class (ℓ = 2) over the entire time interval (Figure 5 (c)); the opposite is true for the hazard
for CV death, with the second class (ℓ = 2) having the greatest hazard for CV death. The base hazard rate
for BC death is most significant at diagnosis (t = 0) and diminishes with time whereas the risk of CV death
increases with time. The base hazard for CV death exceeds the risk of BC death after about 20 years from
diagnosis for those in the first class (ℓ = 1) and after about 16 years for those in the second class (ℓ = 2). This
is generally consistent with previous findings regarding the importance of considering comorbidities for women
with breast cancer [42]. Accordingly, survival against BC death is greater for the less frail second class (ℓ = 2)
than for the first class (ℓ = 1), and survival against CV death is greater in the first class (ℓ = 1) than in the
second class (ℓ = 2). In the relatively frail first class (ℓ = 1), triglyceride levels were found to be associated
with an increased hazard for both CV death (CV, ℓ = 1: HR=6.4, 95% CI=[1.9,22.3], p=0.003) and for BC
death (BC, ℓ = 1: HR=1.6, 95% CI=[0.9,2.8], p=0.09). Standard Cox analysis suggests a weaker association
with an increased hazard against CV death (CV, Cox: HR=1.6, 95% CI=[1.2,2.2], p=0.003) than is suggested
by our analysis, a probable consequence of those members of the cohort for which triglyceride levels are not
associated with increased hazard (ℓ = 2) diluting the effects of those for which triglyceride levels are associated
with increased hazard (ℓ = 1). The same is also true for BC death, for which standard Cox analysis indicates
that triglyceride levels are associated with a modestly increased hazard for BC death (BC, Cox: HR=1.2, 95%
CI [1.0,1.5], p=0.076). Serum glucose was found to be associated with an increased hazard for CV death (CV,
ℓ = 2: HR=1.6, 95% CI=[1.0,2.5], p=0.04) for those in the relatively less frail second class (ℓ = 2), as was
total cholesterol (CV, ℓ = 2: HR=1.7, 95% CI=[0.8,3.5], p=0.18).
In contrast to standard Cox analysis, which suggests that age is associated with a reduced hazard for BC
death for the cohort as a whole (BC, Cox: HR=0.8, 95% CI=[0.6,1.0], p=0.05), our present analysis indicates
that for the majority of the cohort age is associated with an increased hazard for BC death (BC, ℓ = 1:
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Figure 6: Age and survival in women from the AMORIS population diagnosed with breast cancer: In (a) the
age-conditioned Kaplan-Meier estimator for BC death; survival of both the upper and lower quartiles of age
the proportional hazards is poorer than that for the inter-quartile range for age (i.e. the proportional hazards
assumption is not met) and suggests heterogeneity in the cohort. In (b) the class-specific marginal survival
curves, S˜ℓr conditioned on the age covariate (z4), for BC death (r = 1). The substantial difference in survival
against BC death between those in the lower quartile (LQ) and upper quartile (UQ) for age is indicative of
the strength of the association of age with hazard for BC death (see Figure 5). In the more frail first class
(ℓ = 1) survival against BC death decreases with increasing age, while the opposite is true of the second class
(ℓ = 2). However, survival of the second class (ℓ = 2) is actually poorer for younger individuals than it is
for older members of the more frail first class (ℓ = 1). In (c) the time-to-event and age for each individual
having succumbed to BC death is shown, showing a clear stratification, according to age, of the latent classes
to which individuals are retrospectively assigned. Almost all individuals younger than about 50 years old are
assigned to the second latent class (ℓ = 2), whereas those older than about 50 years are assigned to the first
class (ℓ = 1).
HR=3.5, 95% CI=[1.5,8.1], p=004) and is associated with a reduced hazard for BC death for about only one
third of the cohort (BC, ℓ = 2: HR=0.09, 95% CI=[0.02,0.30], p ≈ 10−4). The age of an individual was also
found to be associated with their hazard for CV death, most significantly being strongly associated with an
increased hazard for CV death in the less frail second class (CV, ℓ = 2: HR=42, 95% CI=[16,112], p<10−7).
The age-conditioned risk-specific Kaplan-Meier estimator and class-specific decontaminated survival for BC
death are shown in Figure 6, along with the age, time-to-event, and retrospectively assigned class, for those
individuals recorded as succumbing to BC death. The stratification of the two retrospectively allocated classes
for those individuals succumbing to BC death, occurring clearly between ages about 50 and 55 years, suggest
that menopausal status may be informative as to expected survival against BC death, as shown in Figure 6(c).
Survival against BC death for the more frail first class (ℓ = 1) is greatest for the younger members of the
cohort, with over 80% survival for those in the LQ for age as opposed to less than 50% survival for those in the
UQ for age. In the second class (ℓ = 2) survival against BC death is markedly poorer for younger members of
the cohort as a consequence of age being strongly associated with reduced hazard for BC death for this class.
6 Discussion
In this study, we have introduced a Bayesian latent class approach for survival analysis, designed to deal with
the challenges of residual cohort or disease heterogeneity (i.e. heterogeneity not captured by the available
covariates) and informative censoring by competing risks. Any regression method that, in addition to estimat-
ing crude hazard rates and survival functions, aims to estimate also the marginal hazard rates and survival
probabilities, which would appear to be a prerequisite for distinguishing between real and false covariate pro-
tectivity or aetiology effects, must inevitably make assumptions that are not verifiable from the survival data
alone [1]. Here, the introduction and assumed validity of heterogeneity-induced informative censoring, where
risks are independent only at the level of individuals, in combination with assuming proportional hazards to
hold at the level of individuals, has enabled us to identify the marginal hazard rates and survival functions.
Our (unverifiable) assumption that any risk event time correlations are caused by residual cohort heterogeneity
would appear to be a natural one, and is certainly weaker than assuming uncorrelated risks.
The software package, ALPACA, which implements the formalism introduced herein provides practical tools
for survival analysis which can be applied to heterogeneous cohorts and in the presence of heterogeneity-induced
informative censoring. Cohort parameter estimation is achieved through the combination of i) a latent class
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model which captures, for all risks and for each class, the base hazard rate, covariate associations and relative
frailty, and ii) Bayesianmodel selection to determine the optimal number of classes, the optimal parametrisation
of each base hazard rate, and the extent of heterogeneity in the cohort. Once the optimal quantitative
description of the cohort has been estimated, crude and marginal cause-specific survival curves can be compared
to gauge the extent of any heterogeneity-induced informative censoring, and differences between class-specific
survival curves can be examined. Exploration of correlations between covariate values and retrospectively
assigned class membership can offer additional insight into a cohort, and may aid the search for new informative
biomarkers. Applied to simulated data, our analysis was shown to effectively characterise heterogeneous
cohorts, successfully removing heterogeneity-induced false protectivity and false aetiology effects, and even
discriminating between classes that differ only in their base hazard rates. Retrospective class allocation
was demonstrated to have an impressive accuracy, even for survival data modelling a cohort containing 200
individuals.
On application to survival data from the ULSAM cohort, with prostate cancer as the primary risk, our
analysis leads to plausible alternative explanations for previous counter-intuitive inferences (such as a weak
protective effect on PC of smoking), in terms of distinct sub-groups of patients with distinct risk factors
and overall frailties. In the ULSAM cohort, it was also shown that the men’s metabolic status introduce
competing risk problems, although using traditional methods, several different analyses had to be done to
reveal the underlying risk pattern [40], which with our proposed method could be done coherently in one
analysis.
Applied to survival data for women diagnosed with breast cancer from the AMORIS cohort, our analysis
suggests that for breast cancer death risk the base hazard rate decreases with time but increases with time
for cardiovascular death risk, and the age-class membership correlations may suggest differences in association
patterns and survival against breast cancer between pre- and post-menopausal women.
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A Latent class model: additional details and identities
A.1 Connection between cohort-level and individual-level cause-specific hazard
rates
The relationship between the cohort-level covariate-conditioned cause-specific hazard rate, hr(t|z), and the
hazard rates of the individual members of the cohort, hir(t), is obtained by substitution of p(t0, . . . , tR|z) =∑
i, zi=z
pi(t0, . . . , tR)/
∑
i, zi=z
1 into (1), to give,
hr(t|z)S(t|z) =
∑
i, zi=z
∫∞
0 . . .
∫∞
0 dt0 . . . dtR pi(t0, . . . , tR)δ(t− tr)
∏
r′ 6=r θ(tr′ − t)∑
i, zi=z
1
=
∑
i, zi=z
Si(t)h
i
r(t)∑
i, zi=z
1
. (16)
Insertion of the identity S(t|z) = ∑i, zi=z Si(t)/∑i, zi=z 1 and the individualised survival function, Si(t) =
e
−
∑
r
∫
t
0
ds hir(s), into the above leads to the relationship expressed by (4).
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A.2 Equivalence of crude and marginal survival in the absence of competing risks
We show below that, in the case where a cohort is exposed to only one risk, the crude and marginal survival
functions, Sr(t) and S˜r(t) respectively (6), are equivalent. As only one risk is present (i.e. R = 1), the crude
and marginal cohort-level hazard rates, h1(t|z) and h˜1(t|z) respectively (5), are identical. As the crude and
marginal survival are initially equal (i.e. Sr(t = 0) = S˜r(t = 0) = 1), to prove that they are the same at any
time t, in the absence of any competing risks, it is sufficient to show that their time derivatives are also equal,
as follows,
d
dt
[
lnS1(t|z)− ln S˜1(t|z)
]
= −h1(t|z) +
∑
i,zi=z
hi1(t)e
∫
t
0
ds hi
1
(s)
∑
i,zi=z
e
∫
t
0
ds hi
1
(s)
= −h1(t|z) + h1(t|z) = 0. (17)
A.3 Bayesian retrospective class assignment
Bayesian arguments allow us to calculate class membership probabilities retrospectively for any individual for
whom we have their covariates z and survival information (t, r). The probability of an individual belonging to
class ℓ, conditioned on their covariates and survival information, follows from (11), and is given by,
p(t, r|z, ℓ) = e−Λ0(t) λℓr(t)eβ
ℓ
r
·z−
∑
R
r′=1
exp(β
ℓ
r′
·z)Λℓ
r′
(t). (18)
Given that p(t, r, ℓ|z) = P (t, r|z, ℓ)wℓ and p(t, r|z) =
∑L
ℓ′=1 p(t, r|z, ℓ′)wℓ′ , it follows that the probability of an
individual belonging to class ℓ is given by
p(ℓ|t, r, z) = wℓp(t, r|z, ℓ)∑L
ℓ′=1 wℓ′p(t, r|z, ℓ′)
. (19)
Substitution of p(t, r|z, ℓ) into the above expression leads to the retrospective class membership probability,
as is given for the fully heterogeneous model variant (M = 3) in (10).
A.4 Prior distributions for the latent class model parameters
To estimate a cohort’s characteristics using Bayesian inference (Section 2.5), it is necessary that a prior
distribution, p(θKLM ), on the latent class model parameters, θKLM , be defined. This requires that suitable
prior distributions be chosen to encode any available information regarding the weights, frailties, associations,
and those parameters used in the base hazard rate approximation. In this paper we chose the maximum entropy
prior on the L weight parameters, subject to the constraint
∑
ℓ≤Lwℓ = 1, which is given by p(w1, . . . , wL) =
1/ZL, where ZL =
∫ 1
0 dw1 . . .
∫ 1
0 dwL δ(
∑
ℓ wℓ − 1) = 1/(L−1)! (the so-called flat Dirichlet distribution). Unit-
variance zero-average Gaussian priors were chosen for the frailty and association parameters, justified by our
decision to pre-process the data such that all covariate distributions are normalised (by linear rescaling) to
zero average and unit variance over the cohort. For all (nonnegative) base rate parameters ξkrℓ, see Appendix
A.6, we chose identical exponential priors.
A.5 Model evidence determination using a Gaussian approximation
Estimation of a cohort’s characteristics using Bayesian model selection requires that the model supported by the
greatest ‘evidence’ be determined. The posterior distribution can be written as p(θ|D) = Z−1KLM exp[−S(θ, D)],
where S(θ, D) = − ln[p(θ|HKLM )p(D|θ,HKLM )], and the model evidence is proportional to ZKLM , as given
by
ZKLM =
∫
dθ p(θ|HKLM )p(D|θ,HKLM ). (20)
In our analysis, determination of the evidence (the volume of the posterior) is achieved via a Gaussian approxi-
mation to the posterior, equivalent to making a Taylor expansion of S(θ, D) around its maximum, as described
in e.g. [43]. The posterior is thus approximated by p(θ|D,HKLM ) = Z−1KLM exp[−S(θ⋆)−(θ−θ⋆).A(θ−θ⋆)/2],
where θ⋆ is the location of its maximum and A is the Hessian matrix. The Gaussian-approximation for (20),
Z⋆KLM , is obtained by integrating over the normalised approximated posterior distribution, and is given by,
Z⋆KLM = e
−S(θ⋆)(2π)Y/2(detA)−1/2, (21)
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where Y is the dimensionality of θ. In this work, the matrix A is estimated numerically by investigating the
curvature of the posterior distribution around its maximum.
A.6 Base hazard rate parametrisation using a spline approximation
A standard interpolation method has been chosen for the parametrisation of the cause-specific, and possibly
class-specific, base hazard rates, λℓr(t). A spline construction, with K+1 equidistant time points covering the
range of survival times in a cohort’s survival data, is the basis of the parametrised base hazard rates used in
our analysis. More irregular base hazard rates can be modelled by increasing the number of time points. The
time points are defined by t˜k = tmin + k(tmax−tmin)/K, with k = 0 . . .K, where tmin = mini∈{1,...,N}ti and
tmax = maxi∈{1,...,N}ti are the minimum and maximum survival time in the cohort’s survival data. A base rate
parameter, ξkrℓ, is assigned for each time point t˜k, for each risk r = 0 . . . R, and for each class ℓ = 1, . . . , Ls.
This allows us to define the base hazard rates, λℓr(t), for each risk and class as smooth Gaussian convolutions,
with uniform variation time scale, σ = 12 (t˜k+1− t˜k), as follows,
λℓr(t|ξ) =
∑K
k=0 ξkrℓ e
− 1
2
(t−t˜k)
2/σ2∑K
k=0 e
− 1
2
(t−t˜k)2/σ2
, σ =
tmax − tmin
2K
, t ≥ 0. (22)
where ξ represents the set of all base rate parameters. The integrated rates Λℓr(t|ξ)=
∫ t
0
ds λℓr(s|ξ) are obtained
numerically from (22), via 11-point Gaussian Quadrature, see e.g. [39], applied separately to the n intervals
[jt/n, (j+1)t/n] with j = 0 . . . n−1 and n = 20.
B Generation of simulated time-to-event data
Simulated data, describing risks that are independent at the level of individuals, and with individual cause-
specific hazard rates of the form given in Table 2 was generated as described below. The latent class, ℓ ∈
1, . . . , L, to which each individual, i = 1, . . . , N , belongs is set at the time of generation. Covariate values for
each individual, zµi ∈ N (0, 1), were generated independently from a zero average and unit variance normal
distribution. A latent event time, tri , was generated for each individual and for each risk, r = 1 . . . R, according
to tri (u) = Λ
ℓ,inv
r (exp(−βℓr.zi). log(1/u)) where Λℓ,invr (v) is the inverse of Λℓr(t) =
∫ t
0
ds λℓr(s) and u ∈ [0, 1]
is a uniformly distributed random variable. The outcome data for individual i is that for which the latent
event-time is smallest ti = minr∈{1,...,R}t
r
i , and ri = argminr∈{1,...,R}t
r
i . Should ti exceed the trial duration τ ,
then for individual i we report (ri, ti) = (0, τ).
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